BIOSGN.ST
Biosergen AB
Price:  
0.66 
SEK
Volume:  
22,286.00
Sweden | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BIOSGN.ST WACC - Weighted Average Cost of Capital

The WACC of Biosergen AB (BIOSGN.ST) is 5.5%.

The Cost of Equity of Biosergen AB (BIOSGN.ST) is 7.05%.
The Cost of Debt of Biosergen AB (BIOSGN.ST) is 5.00%.

Range Selected
Cost of equity 5.60% - 8.50% 7.05%
Tax rate 20.60% - 20.90% 20.75%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.8% - 6.2% 5.5%
WACC

BIOSGN.ST WACC calculation

Category Low High
Long-term bond rate 2.5% 3.0%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.6 0.82
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.60% 8.50%
Tax rate 20.60% 20.90%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 4.8% 6.2%
Selected WACC 5.5%